ArticleFrontiers in molecular biosciences2022

Validation of Deep Learning-Based DFCNN in Extremely Large-Scale Virtual Screening and Application in Trypsin I Protease Inhibitor Discovery.

Haiping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.